These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34830727)

  • 1. The Use of HSQoL-24 in an Assessment of Quality-of-Life Impairment among Hidradenitis Suppurativa Patients: First Look at Real-Life Data.
    Krajewski PK; Marrón SE; Gomez-Barrera M; Tomas-Aragones L; Gilaberte-Calzada Y; Szepietowski JC
    J Clin Med; 2021 Nov; 10(22):. PubMed ID: 34830727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenitis Suppurativa Quality of Life 24 (HSQoL-24) now available for Polish patients: creation and validation of the Polish language version.
    Krajewski PK; Bardowska K; Matusiak Ł; Szepietowska M; Tyczyńska K; Marron SE; Tomas Aragones L; Szepietowski JC
    Postepy Dermatol Alergol; 2022 Dec; 39(6):1053-1058. PubMed ID: 36686006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-Reported Hidradenitis Suppurativa Severity: Is It Useful for Clinical Practice?
    Krajewski PK; Marrón SE; Tomas Aragones L; Gilaberte-Calzada Y; Szepietowski JC
    Dermatol Ther (Heidelb); 2022 Apr; 12(4):899-909. PubMed ID: 35274220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality-of-Life Impairment among Patients with Hidradenitis Suppurativa: A Cross-Sectional Study of 1795 Patients.
    Krajewski PK; Matusiak Ł; von Stebut E; Schultheis M; Kirschner U; Nikolakis G; Szepietowski JC
    Life (Basel); 2021 Jan; 11(1):. PubMed ID: 33429896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life in Hidradenitis Suppurativa: validation of the HSQoL-24.
    Marron SE; Gomez-Barrera M; Tomas Aragones L; Goni-Navarro A; Vilarrasa-Rull E; Diaz-Diaz RM; Garcia-Latasa de Aranibar FJ; Campos-Rodenas R; Fuentelsaz Del Barrio V; Gilaberte-Calzada Y; Gracia-Cazaña T; Morales-Callaghan AM; Ros-Abarca S; Madrid-Alvarez MB; Puig L
    Acta Derm Venereol; 2021 Aug; 101(8):adv00529. PubMed ID: 34427316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis Suppurativa.
    Marrón SE; Gómez-Barrera M; Tomás-Aragonés L; Díaz Díaz RM; Vilarrasa Rull E; Madrid Álvarez MB; Puig L
    Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):554-560. PubMed ID: 31023484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Burden of Hidradenitis Suppurativa Signs and Symptoms in Quality of Life: Systematic Review and Meta-Analysis.
    Montero-Vilchez T; Diaz-Calvillo P; Rodriguez-Pozo JA; Cuenca-Barrales C; Martinez-Lopez A; Arias-Santiago S; Molina-Leyva A
    Int J Environ Res Public Health; 2021 Jun; 18(13):. PubMed ID: 34206415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hidradenitis Suppurativa in a Large Cohort of Italian Patients: Evaluation of the Burden of Disease.
    Fabbrocini G; Ruina G; Giovanardi G; Dini V; Raone B; Venturini M; Caposiena Caro RD; Veraldi S; Cannavò SP; Merlo G; Bertoldi AM; Fiorentini F; Molinelli E; Atzori L; Bongiorno MR; Lo Re M; Skroza N; Lasagni C; Franchi C; Ardigò M; Di Costanzo L; Stingeni L; Amerio P; Sanna F; Pescitelli L; Broganelli P; De Cupis C; Gualberti G; Saragaglia V; Argenziano G
    Dermatology; 2022; 238(3):487-497. PubMed ID: 34474409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative Quality of Life in Patients with Hidradenitis Suppurativa Utilizing the Hidradenitis Suppurativa Burden of Disease Tool.
    Guart JA; Byers VV; Sasson DC; Bassiri-Tehrani B; Ranzer M; Purnell C
    Cureus; 2021 Feb; 13(2):e13172. PubMed ID: 33575157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients.
    Schneider-Burrus S; Tsaousi A; Barbus S; Huss-Marp J; Witte K; Wolk K; Fritz B; Sabat R
    Front Med (Lausanne); 2021; 8():676241. PubMed ID: 33987196
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychosocial burden of Hidradenitis Suppurativa patients' partners.
    Włodarek K; Głowaczewska A; Matusiak Ł; Szepietowski JC
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1822-1827. PubMed ID: 32003871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of Life in Hidradenitis Suppurativa: An Update.
    Chernyshov PV; Finlay AY; Tomas-Aragones L; Poot F; Sampogna F; Marron SE; Zemskov SV; Abeni D; Tzellos T; Szepietowski JC; Zouboulis CC
    Int J Environ Res Public Health; 2021 Jun; 18(11):. PubMed ID: 34204126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of HiSQOL: A Hidradenitis Suppurativa-Specific Quality of Life Instrument.
    Thorlacius L; Esmann S; Miller I; Vinding G; Jemec GBE
    Skin Appendage Disord; 2019 Jun; 5(4):221-229. PubMed ID: 31367600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Cases of Hidradenitis Suppurativa Treated with Adalimumab at the Department of Dermatology and Venereology, Clinical Hospital Mostar.
    Lovrić I; Brkić J; Ćorluka M; Čović M; Pejić J; Zeljko Penavić J
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):108-110. PubMed ID: 34477078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with Hidradenitis Suppurativa Suffer from Low Health-Related Quality of Life as Measured by the Generic 15D Instrument.
    Hirvonen MJ; Pasternack R; Lipitsä T; Vihervaara A; Harvima R; Ranta M; Sintonen H; Huilaja L
    Skin Appendage Disord; 2022 May; 8(3):221-227. PubMed ID: 35702276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Broad-Spectrum Impact of Hidradenitis Suppurativa on Quality of Life: A Comparison with Psoriasis.
    Sampogna F; Fania L; Mazzanti C; Caggiati A; Pallotta S; Panebianco A; Mastroeni S; Didona B; Pintori G; Abeni D
    Dermatology; 2019; 235(4):308-314. PubMed ID: 31121589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unmet clinical needs and burden of disease in hidradenitis suppurativa: real-world experience from EU5 and US.
    Ingram JR; Bettoli V; Espy JI; Kokolakis G; Martorell A; Villani AP; Wallinger H; Coak E; Kasparek T; Muscianisi E; Richardson C; Kimball AB
    J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1597-1605. PubMed ID: 35445469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous body image in patients with hidradenitis suppurativa: a hospital-based cross-sectional study.
    Koumaki D; Rovithi E; Solia Apokidou E; Papadakis M; Katoulis A; Evangelou G
    Sci Rep; 2023 May; 13(1):7898. PubMed ID: 37193758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improvement in Hidradenitis Suppurativa and quality of life in patients treated with adalimumab: Real-world results from the HARMONY Study.
    Hafner A; Ghislain PD; Kovács R; Batchelor R; Katoulis AC; Kirby B; Banayan H; Schonbrun M
    J Eur Acad Dermatol Venereol; 2021 Nov; 35(11):2277-2284. PubMed ID: 34320249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life measurement in hidradenitis suppurativa: position statement of the European Academy of Dermatology and Venereology task forces on Quality of Life and Patient-Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa.
    Chernyshov PV; Zouboulis CC; Tomas-Aragones L; Jemec GB; Svensson A; Manolache L; Tzellos T; Sampogna F; Pustisek N; van der Zee HH; Marron SE; Spillekom-van Koulil S; Bewley A; Linder D; Abeni D; Szepietowski JC; Augustin M; Finlay AY
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1633-1643. PubMed ID: 31037773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.